The Department of Health and Social Care (DHSC) has today (29/07/2022) granted the following list of price concessions: Please note this is not the final update for July 2022. A few lines are still under discussion with DHSC, and we expect to issue a further update early next week to complete July 2022 price concessions. [...]
The post July Price Concessions 4th Update appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (26/07/2022) granted the following list of price concessions: Drug Pack size Price concession Flecainide 100mg tablets 60 £4.52 Fluoxetine 20mg capsules 30 £1.80 Ibuprofen 100mg/5ml oral suspension sugar free 100 £3.99 Lacidipine 2mg tablets 28 £2.95 Loratadine 5mg/5ml oral solution 100 £4.72 Rizatriptan 10mg tablets [...]
The post July 2022 Price Concessions 3rd Update appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (22/07/2022) granted the following list of price concessions: Drug Pack size Price concession Celecoxib 200mg capsules 30 £5.97 Clarithromycin 250mg/5ml oral suspension 70 £5.00 Clotrimazole 500mg pessaries 1 £5.20 Cyclizine 50mg/1ml solution for injection ampoules 5 £6.16 Desloratadine 5mg tablets 30 £4.91 Flucloxacillin 500mg capsules [...]
The post July 2022 Price Concessions 2nd Update appeared first on PSNC Website.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 12 July 2022) has been published and includes articles on: Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure COVID-19 vaccines and medicines: updates for July 2022 [...]
The post MHRA Drug Safety Update July 2022 appeared first on PSNC Website.
Class 4 Medicines Defect Information: NovoRapid® FlexTouch® 100 units/ml and Saxenda® FlexTouch® (liraglutide) 6mg/ml (Novo Nordisk Limited) Drug alert number: EL (22)A/33 Date issued: 21 July 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Novorapid FlexTouch 100units/ml solution for injection in pre-filled pen (insulin [...]
The post MHRA Class 4 Medicines Defect Information: NovoRapid FlexTouch 100units/ml and Saxenda FlexTouch 6mg/ml appeared first on PSNC Website.
Recent Comments